Dogwood Therapeutics, Inc. cotiza a 1.33 USD y tiene una capitalización bursátil de $45M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, wh…
| Métrica | DWTX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -45.7% | -40.4% | -5.3% |
| ROA | -38.0% | -32.0% | -6.0% |
| Current Ratio | 2.76 | 2.84 | -0.08 |
| Debt / Equity | — | 0.28 | — |